CRCT trades 12.2% above Wall Street's consensus target of $3.88.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CRCT achieves its forward estimates and maintains a stable P/E multiple of 23.0x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 7, 2026, Cricut, Inc. (CRCT) has a Wall Street consensus price target of $3.88, based on estimates from 4 covering analysts. With the stock currently trading at $4.42, this represents a potential downside of -12.2%. The company has a market capitalization of $928M.
Analyst price targets range from a low of $3.75 to a high of $4.00, representing a 6% spread in expectations. The median target of $3.88 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Sell, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 4 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CRCT trades at a trailing P/E of 12.6x and forward P/E of 23.0x. Analysts expect EPS to grow -44.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $3.95, with bear and bull scenarios of $2.49 and $5.21 respectively. Model confidence stands at 38/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
SONOSonos, Inc. | $1.6B | $13.60 | $19.50 | +43.4% | Buy | 34.9x | 9 |
LOGILogitech International S.A. | $14.0B | $97.43 | $109.00 | +11.9% | Hold | 17.7x | 19 |
GPROGoPro, Inc. | $126M | $0.74 | $5.00 | +576.8% | Hold | 14.8x | 28 |
SSYSStratasys Ltd. | $730M | $8.47 | $12.50 | +47.6% | Buy | 70.6x | 36 |
DDD3D Systems Corporation | $416M | $2.83 | $5.00 | +76.7% | Hold | — | 36 |
XMTRXometry, Inc. | $4.7B | $94.30 | $75.00 | -20.5% | Buy | 133.1x | 14 |
BRZEBraze, Inc. | $2.7B | $24.15 | $32.33 | +33.9% | Buy | 38.1x | 25 |
ETSYEtsy, Inc. | $7.1B | $75.06 | $71.00 | -5.4% | Buy | 21.0x | 45 |
AMZNAmazon.com, Inc. | $2.6T | $244.16 | $307.77 | +26.1% | Buy | 27.7x | 94 |
ADBEAdobe Inc. | $86.7B | $218.07 | $260.12 | +19.3% | Buy | 9.0x | 63 |
Quick answers to the most common questions about buying CRCT stock.
CRCT's consensus price target is $3.88, -12.2% below the current price of $4.42. The 4 analysts tracking CRCT see downside risk at present valuations.
CRCT has a consensus rating of "Sell" based on 4 Wall Street analysts. The rating breakdown is leaning bearish, with 4 Sell/Strong Sell ratings. The consensus 12-month price target of $3.88 implies -12.2% downside from current levels.
CRCT trades at a forward P/E of 22.961x, representing a moderate valuation. With analysts targeting $3.88 (-12.2% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $4 for CRCT, while the most conservative target is $3.75. The consensus of $3.88 represents the median expectation. Our quantitative valuation model projects a bull case target of $5 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRCT is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRCT stock forecast based on 4 Wall Street analysts shows a consensus price target of $3.88, with estimates ranging from $3.75 (bear case) to $4 (bull case). The median consensus rating is "Sell". Our proprietary valuation model produces a base case fair value of $4, with bear/bull scenarios of $2/$5.
Our quantitative valuation model calculates CRCT's fair value at $4 (base case), with a bear case of $2 and bull case of $5. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 38/100.
CRCT trades at a forward P/E ratio of 23.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.6x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CRCT, with 4 Sell ratings and a price target of $3.88 (-12.2% from current price). The "Sell" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRCT analyst price targets range from $3.75 to $4, a 6% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $3.88 consensus represents the middle ground. Our model's $2-$5 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.